Inhaled Corticosteroid Device Market Research Report – Forecast to 2023

Inhaled Corticosteroid Device Market Research Report – Forecast to 2023

ID: MRFR/HC/4953-HCRR | November, 2018 | Region: Global | 100 pages | Half-Cooked Research Reports

Global Inhaled Corticosteroid Device Market, by Types of Steroid Inhalers (Beclomethasone Dipropionate, Budesonide, Fluticasone, Mometasone, and Others), by Application (Asthma, COPD, and Others), by End-Users (Hospitals and Others) – Forecast Till 2023 


Market Scenario


The global inhaler corticosteroid device market is expected to grow during the forecast period (2018 to 2023) at a CAGR of ~ 6.2 %.


Asthma is a disease of the entire respiratory tract, including large, intermediate and small airways. Asthma led to inflammation and obstruction of respiratory tract. Patients have various treatment options for asthma, particularly for young and elderly patients. Hence this has led to significant interest on the part of the inhaler device which is easy to use. Inhaled corticosteroid is the most commonly used tool for the treatment of asthma. As with increasing pollution and increasing incidences of asthma, many companies are engaged in the development of new inhaler corticosteroid devices. Hence this factor is responsible for the growth of the inhaled corticosteroid device market.


However, the high cost of treatment, misuse of funding and lack of awareness are some of the factors which are hampering the growth of the market during the forecast period.


Segmentation


The global inhaler corticosteroid device market is segmented into types of steroid inhalers, applications, and end-users. Based on types of steroid inhaler the market is segmented into beclomethasone dipropionate, budesonide, fluticasone inhaler powder, mometasone. On the basis of application, inhaler corticosteroid device market is segmented into asthma and COPD (chronic obstructive pulmonary disease), and other respiratory diseases. Based on end-user the market is segmented into hospitals, clinics, and respiratory care centers.  


Key players


Some of the key players in the global inhaler corticosteroid device market are Plumage Therapeutics LLP, Pearl Therapeutic Inc, Teijin LTD, Glaxo’s Advair, LIYEN, Inc, Amgen Inc, Kos Pharmaceutical, Inc, and Teva Pharmaceutical.  


Regional Market Summary


Global Inhaler Corticosteroid Device Market Share, by Region, 2018 (%)


Inhaler Corticosteroid Device Market Share


Source: MRFR Analysis


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The inhaler corticosteroid device market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European inhaler corticosteroid device market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The inhaler corticosteroid device market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The inhaler corticosteroid device market in the Middle East and Africa has been segmented into the Middle East and Africa.


In terms of market value, North America will dominate the inhaler corticosteroid device market during the forecast period. Increasing incidences of life-threatening illness such as chronic obstructive pulmonary disease, asthma and many more are some of the factors which are responsible for the growth of the market during the forecast period. The European market is expected to be the second-largest inhaler corticosteroid device market. The market growth in this region can be attributed to government funding and support of the healthcare sector coupled with increasing research and development. Moreover, a growing patient for asthma worldwide, increasing number of qualified physicians for inhaler corticosteroid device center and expanding aging demographics are some of the factors responsible for the rise in global inhaler corticosteroid device market. Asia-Pacific is expected to be the fastest-growing inhaler corticosteroid device market during the forecast period owing to the increasing prevalence of asthma, rising investments in healthcare, increasing geriatric population, and expansions by market players in the region. Asia-Pacific is giving the strong competition in the global inhaler corticosteroid device market by producing a cost-effective treatment that is high in demand in local as well as in the global market. The market in the Middle East and Africa is expected to account for the smallest share in the global inhaler corticosteroid device market due to the underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Global Inhaler Corticosteroid Device Market, by Steroid Inhaler Types



  • Beclomethasone Dipropionate

  • Budesonide

  • Fluticasone Inhaler Powder

  • Mometasone


Global Inhaler Corticosteroid Device Market, by Application



  • Asthma

  • COPD (Chronic Obstructive Pulmonary Disease)

  • Others


Global Inhaler Corticosteroid Device Market, by End-User



  • Hospitals and Clinics

  • Academic and Research Institutes

  • Respiratory Care Center


Global Inhaler Corticosteroid Device Market, by Region


Americas


  • North America

  • US

  • Canada

  • South America


Europe


  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe


Asia-Pacific


  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific


Middle East & Africa


  • Middle East

  • Africa


Intended Audience



  • Hospitals and clinics

  • Laboratories and associations

  • Healthcare providers

  • Medical device manufacturers

  • Research institutes and academic centers

  • Government associations

  • Market research and consulting

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Inhaler Corticosteroid Device Market, by Types

6.1 Introduction

6.2 Beclomethasone Dipropionate

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3 Budesonide

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.4 Fluticasone Inhaler Powder

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.5 Mometasone

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023



Chapter 7. Global Inhaler Corticosteroid Device Market, by Applications

7.1 Introduction

7.2 Asthma

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3 COPD (Chronic Obstructive Pulmonary Disease)

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023



Chapter 8. Global Inhaler Corticosteroid Device Market, by End-Users

8.1 Introduction

8.2 Hospitals

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3 Clinics

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.4 Respiratory Care Center

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023



Chapter 9. Global Inhaler Corticosteroid Device Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Plumage Therapeutics LLP

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Pearl Therapeutic Inc

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Teijin LTD

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Glaxo’s Advair

11.4.1 Company Overview

11.4.2 Technology/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11. 5 LIYEN, Inc

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Amgen Inc

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Kos Pharmaceutical, Inc

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Teva Pharmaceutical

11.8.1 Overview

11.8.2 Product/ Technology Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis



Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

Chapter 13. Appendix



LIST OF TABLES

Table 1 Global Inhaler Corticosteroid Device Market Synopsis, 2018–2023

Table 2 Global Inhaler Corticosteroid Device Market Estimates and Forecast, 2018–2023 (USD Million)

Table 3 Global Inhaler Corticosteroid Device Market, by Region, 2018–2023 (USD Million)

Table 4 Global Inhaler Corticosteroid Device Market, by Types, 2018–2023 (USD Million)

Table 5 Global Inhaler Corticosteroid Device Market, by End-Users, 2018–2023 (USD Million)

Table 6 North America: Inhaled Corticosteroid Device Market, by Types, 2018–2023 (USD Million)

Table 7 North America: Inhaled Corticosteroid Device Market, by End-Users, 2018–2023 (USD Million)

Table 8 US: Inhaled Corticosteroid Device Market, by Types, 2018–2023 (USD Million)

Table 9 US: Inhaled Corticosteroid Device Market, by End-Users, 2018–2023 (USD Million)

Table 10 Canada: Inhaled Corticosteroid Device Market, By Types, 2018–2023 (USD Million)

Table 11 Canada: Inhaled Corticosteroid Device Market, by End-Users, 2018–2023 (USD Million)

Table 12 South America: Inhaled Corticosteroid Device Market, by Types, 2018–2023 (USD Million)

Table 13 South America: Inhaled Corticosteroid Device Market, by End-Users, 2018–2023 (USD Million)

Table 14 Europe: Inhaled Corticosteroid Device Market, by Types, 2018–2023 (USD Million)

Table 15 Europe: Inhaled Corticosteroid Device Market, by End-Users, 2018–2023 (USD Million)

Table 16 Western Europe: Inhaled Corticosteroid Device Market, by Types, 2018–2023 (USD Million)

Table 17 Western Europe: Inhaled Corticosteroid Device Market, by End-Users, 2018–2023 (USD Million)

Table 18 Eastern Europe: Inhaled Corticosteroid Device Market, by Types, 2018–2023 (USD Million)

Table 19 Eastern Europe: Inhaled Corticosteroid Device Market, by End-Users, 2018–2023 (USD Million)

Table 20 Asia-Pacific: Inhaled Corticosteroid Device Market, by Types, 2018–2023 (USD Million)

Table 21 Asia-Pacific: Inhaled Corticosteroid Device Market, by End-Users, 2018–2023 (USD Million)

Table 22 Middle East & Africa: Inhaled Corticosteroid Device Market, by Types, 2018–2023 (USD Million)

Table 23 Middle East & Africa: Inhaled Corticosteroid Device Market, by End-Users, 2018–2023 (USD Million)



LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Inhaler Corticosteroid Device Market

Figure 3 Segmentation Market Dynamics for Global Inhaler Corticosteroid Device Market

Figure 4 Global Inhaler Corticosteroid Device Market Share, By Types, 2018

Figure 5 Global Inhaler Corticosteroid Device Market Share, By End-Users, 2018

Figure 6 Global Inhaler Corticosteroid Device Market Share, By Region, 2018

Figure 7 North America: Global Inhaler Corticosteroid Device Market Share, By Country, 2018

Figure 8 Europe: Global Inhaler Corticosteroid Device Market Share, By Country, 2018

Figure 9 Asia-Pacific: Global Inhaler Corticosteroid Device Market Share, By Country, 2018

Figure 9 Middle East & Africa: Global Inhaler Corticosteroid Device Market Share, By Country, 2018

Figure 10 Global Inhaler Corticosteroid Device Market: Company Share Analysis, 2018 (%)

Figure 11 Plumage Therapeutics LLP: Key Financials

Figure 12 Plumage Therapeutics LLP: Segmental Revenue

Figure 14 Plumage Therapeutics LLP: Geographical Revenue

Figure 15 Pearl Therapeutic Inc.: Key Financials

Figure 16 Pearl Therapeutic Inc.: Segmental Revenue

Figure 17 Pearl Therapeutic Inc.: Geographical Revenue

Figure 18 Teijin LTD: Key Financials

Figure 19 Teijin LTD: Segmental Revenue

Figure 20 Teijin LTD: Geographical Revenue

Figure 21 Glaxo’s Advair: Key Financials

Figure 22 Glaxo’s Advair: Segmental Revenue

Figure 23 Glaxo’s Advair: Geographical Revenue

Figure 24 LIYEN, Inc: Key Financials

Figure 25 LIYEN, Inc: Segmental Revenue

Figure 26 LIYEN, Inc: Geographical Revenue

Figure 27 Amgen Inc: Key Financials

Figure 28 Amgen Inc :Segmental Revenue

Figure 29 Amgen Inc :Geographical Revenue

Figure 30 Kos Pharmaceutical, Inc: Key Financials

Figure 31 Kos Pharmaceutical, Inc: Segmental Revenue

Figure 32 Kos Pharmaceutical, Inc: Geographical Revenue

Figure 33 Teva Pharmaceutical: Key Financials

Figure 34 Teva Pharmaceutical: Segmental Revenue

Figure 35 Teva Pharmaceutical: Geographical Revenue